Skip to main content

Table 1 Male patients with adrenoleukodystrophy: comparison of demographics by adrenal insufficiency (AI)

From: Adrenal insufficiency and the use of mineralocorticoid treatment in male patients with adrenoleukodystrophy; a retrospective analysis of an institutional database

Variable

All ALD2 male patients (N = 358)

Diagnosis of AI3 (N = 213)

No diagnosis of AI2 (N = 145)

P-value1

Age, median (range)

14.0 (0.0, 92.0)

16.0 (1.0, 68.0)

11.0 (0.0, 92.0)

< 0.001

Race4, n (%)

   

0.540

 White

231 (64.5%)

142 (66.7%)

89 (61.4%)

 Asian

20 (5.6%)

10 (4.7%)

10 (6.9%)

 American Indian or Alaska Native

6 (1.7%)

2 (0.9%)

4 (2.8%)

 More than 1 race

3 (0.8%)

2 (0.9%)

1 (0.7%)

 Unknown

98 (27.4%)

57 (26.8%)

41 (28.3%)

Ethnicity4, n (%)

   

0.154

 Hispanic or Latino

28 (7.8%)

15 (7.0%)

13 (9.0%)

 Not Hispanic or Latino

266 (74.3%)

166 (77.9%)

100 (69.0%)

 Unknown

64 (17.9%)

32 (15.0%)

32 (22.1%)

  1. 1Wilcoxon rank-sum test was used for age. Chi-square or Fisher’s exact tests were used for categorical variables. 2ALD: Adrenoleukodystrophy; 3AI: adrenal insufficiency; 4Race and ethnicity are self-report